NCT00416637View on ClinicalTrials.gov

Bevacizumab in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

Bevacizumab (Avastin)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Herbert Hurwitz, MD

OTHER

NCT00416637 - Bevacizumab in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter